Rigel Pharmaceuticals, Inc. (RIGL)
NMS – Real vaqt narxi. Valyuta: USD
42.55
+0.53 (1.26%)
Bozor ochiq: Aug 12, 2026, 11:16 AM EDT
42.39
+0.37 (0.88%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
42.55
+0.53 (1.26%)
Bozor ochiq: Aug 12, 2026, 11:16 AM EDT
42.39
+0.37 (0.88%)
Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Kompaniyaning naqd pul zahiralari $60.8M umumiy qarzdan $40.0M sezilarli darajada ko'p bo'lib, kuchli moliyaviy moslashuvchanlikni ta'minlaydi
Jami joriy aktivlar $185.5M jami joriy majburiyatlardan $95.6M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (0.1) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (41x) kompaniya qarz to'lovlarini osonlik bilan boshqarishini ko'rsatadi
Kompaniya ijobiy erkin pul oqimi $30.7M generatsiya qiladi, moliyaviy salomatligini qo'llab-quvvatlaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.94 | 6.05 | 9.0 | |
| Tezkor likvidlik nisbati | 1.79 | 5.63 | 9.0 | |
| Qarz/Kapital nisbati | 0.09 | 0.30 | 9.0 | |
| Qarz/Aktivlar nisbati | 0.08 | 1.04 | 9.0 | |
| Foiz to‘lov qoplami | 41.36 | -16.91 | 10 | |
| O‘rtacha ball | 9.2 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 120M | 117M | 179M | 294M | 277M |
| Yalpi foyda | 118M | 110M | 161M | 275M | 253M |
| Operatsion daromad | -54M | -20M | 24M | 125M | 87M |
| Sof foyda | -59M | -25M | 17M | 367M | 322M |
| EBITDA | -53M | -19M | 26M | 128M | 90M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 13.34 | -38.85 | 4.5 |
| Keyingi chorak | 24.72 | -92.5 | 5.5 |
| Joriy yil | 2.25 | -82.71 | 2.0 |
| Keyingi yil | 19.1 | 23.96 | 9.5 |
| O‘rtacha ball | 5.4 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 33.81 | 99.79 | 100 | 1024.88 | 10 |
| Yil/Yil | -22.59 | -70.99 | -73.16 | 0.38 | 1.3 |
| 3 yil o‘rtacha | 38.25 | 741.98 | 699.07 | 293.43 | 10 |
| 5 yil o‘rtacha | 26.54 | 407.75 | 385.4 | -104.61 | 7.8 |
| O‘rtacha ball | 7.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |